BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rizvi AA, Janez A, Rizzo M. Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues. Int J Mol Sci 2021;22:12311. [PMID: 34830193 DOI: 10.3390/ijms222212311] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Mainas G, Nibali L, Ide M, Mahmeed WA, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Firenze A, Galia M, Goh SY, Janež A, Kalra S, Kapoor N, Kempler P, Lessan N, Lotufo P, Papanas N, Rizvi AA, Sahebkar A, Santos RD, Stoian AP, Toth PP, Viswanathan V, Rizzo M; CArdiometabolic Panel of International Experts on Syndemic COVID-19 (CAPISCO). Associations between Periodontitis, COVID-19, and Cardiometabolic Complications: Molecular Mechanisms and Clinical Evidence. Metabolites 2022;13. [PMID: 36676965 DOI: 10.3390/metabo13010040] [Reference Citation Analysis]
2 Kapoor N, Kalra S, Al Mahmeed W, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Firenze A, Galia M, Goh SY, Janez A, Kempler P, Lessan N, Lotufo P, Papanas N, Rizvi AA, Sahebkar A, Santos RD, Stoian AP, Toth PP, Viswanathan V, Rizzo M; CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO). The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact. Diabetes Ther 2022;13:1723-36. [PMID: 36030317 DOI: 10.1007/s13300-022-01311-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Janež A, Ješe R, Haluzík M, Rizzo M. The Role of Physicians' Digital Tools in Pharmacological Management of Type 2 Diabetes Mellitus. Medicina (Kaunas) 2022;58:1061. [PMID: 36013528 DOI: 10.3390/medicina58081061] [Reference Citation Analysis]
4 Janez A, Muzurovic E, Stoian AP, Haluzik M, Guja C, Czupryniak L, Duvnjak L, Lalic N, Tankova T, Bogdanski P, Papanas N, Nunes JS, Kempler P, Fras Z, Rizzo M. Translating results from the cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists into clinical practice: Recommendations from a Eastern and Southern Europe diabetes expert group. Int J Cardiol 2022:S0167-5273(22)01085-3. [PMID: 35905827 DOI: 10.1016/j.ijcard.2022.07.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Li Z, Huang Q, Yang X, Zeng J, Wang Q, Tang H, Yu Z, Song Y, Liu Y, Rizzo M. Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia. Disease Markers 2022;2022:1-9. [DOI: 10.1155/2022/2008556] [Reference Citation Analysis]
6 Ilias I, Rizzo M, Zabuliene L. Metformin: Sex/Gender Differences in Its Uses and Effects—Narrative Review. Medicina 2022;58:430. [DOI: 10.3390/medicina58030430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]